Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-22 5:15 pm Purchase | 2025-12-19 | 13G | IN8bio, Inc. INAB | Stonepine Capital Management, LLC | 1,007,990 9.900% | 1,007,990 (New Position) | Filing History |
| 2025-12-16 4:04 pm Purchase | 2025-12-10 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | Stonepine Capital Management, LLC | 3,030,926 9.900% | 3,030,926 (New Position) | Filing History |
| 2025-11-13 4:19 pm Sale | 2025-09-30 | 13G | Verastem, Inc. VSTM | Stonepine Capital Management, LLC | 2,670,032 4.300% | -163,301 (-5.76%) | Filing History |
| 2025-11-04 12:19 pm Purchase | 2025-10-29 | 13G | CNS Pharmaceuticals, Inc. CNSP | Stonepine Capital Management, LLC | 32,220 5.600% | 32,220 (New Position) | Filing History |
| 2025-09-08 5:44 pm Purchase | 2025-09-02 | 13G | Kezar Life Sciences, Inc. KZR | Stonepine Capital Management, LLC | 377,240 5.200% | 377,240 (New Position) | Filing History |
| 2025-08-13 4:16 pm Purchase | 2025-06-30 | 13G | Aytu BioPharma, Inc. AYTU | Stonepine Capital Management, LLC | 906,063 9.900% | 279,201 (+44.54%) | Filing History |
| 2025-08-13 4:08 pm Purchase | 2025-06-30 | 13G | Surrozen, Inc. SRZN | Stonepine Capital Management, LLC | 508,687 5.800% | 176,236 (+53.01%) | Filing History |
| 2025-08-06 1:10 pm Purchase | 2025-07-22 | 13G | Verastem, Inc. VSTM | Stonepine Capital Management, LLC | 2,833,333 5.000% | 630,000 (+28.59%) | Filing History |
| 2025-05-14 4:14 pm Purchase | 2025-03-31 | 13G | Surrozen, Inc. SRZN | Stonepine Capital Management, LLC | 332,451 9.900% | 87,793 (+35.88%) | Filing History |
| 2025-05-14 4:12 pm Purchase | 2025-03-31 | 13G | OptiNose, Inc. OPTN | Stonepine Capital Management, LLC | 788,647 7.800% | 199,990 (+33.97%) | Filing History |
| 2025-05-14 4:10 pm Sale | 2025-03-31 | 13G | Inovio Pharmaceuticals, Inc. INO | Stonepine Capital Management, LLC | 1,434,997 3.800% | -481,669 (-25.13%) | Filing History |
| 2025-05-14 4:07 pm Sale | 2025-03-31 | 13G | CalciMedica, Inc. CALC | Stonepine Capital Management, LLC | 628,672 4.600% | -113,029 (-15.24%) | Filing History |
| 2025-05-14 4:04 pm Sale | 2025-03-31 | 13G | Aprea Therapeutics, Inc. APRE | Stonepine Capital Management, LLC | 239,416 4.300% | -46,979 (-16.40%) | Filing History |
| 2025-02-25 5:16 pm Purchase | 2025-02-13 | 13G | Edesa Biotech, Inc. EDSA | Stonepine Capital Management, LLC | 693,551 9.900% | 693,551 (New Position) | Filing History |
| 2025-02-13 12:38 pm Purchase | 2024-12-31 | 13G | OptiNose, Inc. OPTN | Stonepine Capital Management, LLC | 588,657 5.900% | 588,657 (New Position) | Filing History |
| 2025-02-13 12:32 pm Sale | 2024-12-31 | 13G | Verastem, Inc. VSTM | Stonepine Capital Management, LLC | 2,203,333 4.800% | -440,287 (-16.65%) | Filing History |
| 2025-02-13 12:15 pm Sale | 2024-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Stonepine Capital Management, LLC | 286,395 5.100% | -79,041 (-21.63%) | Filing History |
| 2025-02-13 12:07 pm Sale | 2024-12-31 | 13G | TELA Bio, Inc. TELA | Stonepine Capital Management, LLC | 2,353,099 6.000% | -478,740 (-16.91%) | Filing History |
| 2024-12-23 8:08 pm Purchase | 2024-12-17 | 13G | Inovio Pharmaceuticals, Inc. INO | Stonepine Capital Management, LLC | 1,916,666 5.200% | 1,916,666 (New Position) | Filing History |
| 2024-12-13 2:55 pm Purchase | 2024-12-06 | 13G | CalciMedica, Inc. CALC | Stonepine Capital Management, LLC | 741,701 5.400% | 741,701 (New Position) | Filing History |